Document:

Form of Registration Rights Agreement

 Exhibit 10.12 
 REGISTRATION RIGHTS AGREEMENT 
 This Registration Rights Agreement (this “Agreement”) is
made as of                     , 2006, by and among Trans-India Acquisition Corporation, a Delaware corporation (the “Company”), and
the undersigned parties listed under the heading “Investors” on the signature page hereto (each, an “Investor” and collectively, the “Investors”). 
 WHEREAS, the Investors currently hold all of the issued and outstanding securities of the Company; 
  WHEREAS, certain of the Investors will purchase an aggregate of 200,000 Units (as defined below) from the Company in private placements immediately prior
to the closing of the Initial Public Offering (as defined below); 
  WHEREAS, the Investors and the Company desire to enter into this
Agreement to provide the Investors with certain rights relating to the registration of securities held by them; 
 NOW THEREFORE, in
consideration of the mutual agreements herein contained, the parties hereto agree as follows: 
 1. Definitions. The following capitalized terms used
herein have the following meanings: 
 “Agreement” means this Agreement, as amended, restated, supplemented, or otherwise modified
from time to time. 
 “Blackout Period” means the period (A) beginning ninety (90) days prior to the date the Company
expects to file a Registration Statement for a public offering (other than a registration statement relating to any employee benefit plan, or a registration statement related solely to stock issued upon conversion of debt securities) and, in the
event no such Registration Statement is filed, ending on the earlier of ninety (90) days thereafter or the date that the Company no longer expects to file such Registration Statement or, in the event such a Registration Statement is filed,
ending on the last day of the distribution (as contemplated in Regulation M under the Securities Exchange Act of 1934, as amended) of such public offering of securities; or (B) beginning on the date following a determination of the
Company’s board of directors made in the good faith judgment of such board of directors that it would be materially detrimental to the Company and its stockholders for such Registration Statement to be effected at such time, ending on the
earlier of ninety (90) days thereafter or the date on which the Company’s board of directors determines that it would no longer be materially detrimental to the Company and its stockholders for such Registration Statement to be effected at
such time. 
 “Commission” means the Securities and Exchange Commission, or any other federal agency then administering the
Securities Act or the Exchange Act. 
 “Common Stock” means the common stock, par value $0.0001 per share, of the Company.

 “Company” is defined in the preamble to this Agreement. 
  

 1 

 “Demand Registration” is defined in Section 2.1.1. 
 “Demanding Holder” is defined in Section 2.1.1. 
 “Effective Date” means the date of effectiveness of the registration statement filed with the Commission in connection with the Initial Public Offering. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder,
all as the same shall be in effect at the time. 
 “Form S-3” is defined in Section 2.3. 
 “Indemnified Party” is defined in Section 4.3. 
 “Indemnifying Party” is defined in Section 4.1. 
 “Initial Public Offering” means
the Company’s initial public offering pursuant to the Securities Act. 
 “Investor” is defined in the preamble to this
Agreement. 
 “Investor Indemnified Party” is defined in Section 4.1. 
 “Maximum Number of Securities” is defined in Section 2.1.4. 
 “Piggy-Back Registration” is defined in Section 2.2.1. 
 “Register,”
“registered” and “registration” mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations
promulgated thereunder, and such registration statement becoming effective. 
  “Registrable Securities” mean the Units, all of
the shares of Common Stock and Warrants underlying the Units and owned or held by the Investors or the Transferees and the shares of Common Stock issuable upon exercise of the Warrants. Registrable Securities include any warrants, shares of capital
stock or other securities of the Company issued as a dividend or other distribution with respect to or in exchange for or in replacement of such shares of Common Stock and/or Warrants. As to any particular Registrable Securities, such securities
shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or
exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Company and
subsequent public distribution of them shall not require registration under the Securities Act; or (C) such securities shall have ceased to be outstanding. In addition, Registrable Securities shall not include any securities held by any holder
if such securities are then saleable under Rule 144 or Rule 905 in the opinion of counsel to the Company. 
   

 2 

 “Registration Statement” means a registration statement filed by the Company with the
Commission in compliance with the Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of Common Stock (other than a registration statement on Form S-4 or Form S-8, or their successors, or any
registration statement covering only securities proposed to be issued in exchange for securities or assets of another entity). 
 “Release Date” means the date on which shares of Common Stock are disbursed from escrow pursuant to Section 3 of that certain Securities Escrow Agreement dated as of
                    , 2006 by and among the parties hereto and Continental Stock Transfer & Trust Company. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder, all as
the same shall be in effect at the time. 
 “Transferee” or “Transferees” means the persons, trusts or entities to whom
the Registrable Securities are transferred (i) by gift to a member of Investor’s immediate family or to a trust, the beneficiary of which is an Investor or a member of an Investor’s immediate family, (ii) by virtue of the laws of
descent and distribution upon death of any Investor, (iii) pursuant to a qualified domestic relations order, or (iv) pursuant to a transfer of record ownership whereby there is no change in beneficial ownership. 
 “Underwriter” means a securities dealer who purchases any Registrable Securities as principal in an underwritten offering and not as part of
such dealer’s market-making activities. 
  “Units” mean the Company’s Units sold to certain of the Investors
immediately prior to the Initial Public Offering pursuant to that certain Subscription Agreement and Regulation S Subscription Agreement and to certain of the Investors in connection with the initial capitalization, whereby each unit consists of one
share of Common Stock and one Warrant. 
  “Warrants” means those warrants to purchase shares of Common Stock of the Company
expiring five years from the Effective Date. 
 2. Registration Rights. 
 2.1. Demand Registration. 
 2.1.1. Grant of Demand Right. The Company, upon the
receipt of the Initial Demand Notice (as defined below) of the Investors or Transferees holding at least thirty percent (30%) (collectively, the “Demanding Holders”) of the Registrable Securities, agrees to register on no more than
two occasions, all or any portion of the Registrable Securities requested by the Demanding Holders in the Initial Demand Notice. With respect to such registration request, the Company will use its commercially reasonable efforts to file a
Registration Statement covering the Registrable Securities as soon as reasonably practicable, but no later sixty (60) days after the Company receives notice from the Demanding Holders indicating their desire that the Company commence the
preparation of and effect the filing of a registration statement with the Commission as to the Registrable Securities (the “Initial Demand Notice”), and, upon filing, use its commercially reasonable efforts to have such Registration
Statement declared effective as soon as practicable thereafter; provided, that the Company shall be deemed to have complied 

  

 3 

 
with its obligation hereunder so long as it has made such commercially reasonable efforts. Notwithstanding the foregoing, if the Company provides the
Demanding Holders notice of a Blackout Period within seven business days after it receives the Initial Demand Notice, then: (A) the Company’s obligation to take any action pursuant to this Section 2.1.1, including to file a
Registration Statement covering the Registrable Securities, shall be suspended during the Blackout Period; (B) the Initial Demand Notice shall thereupon be deemed to have been received, for purposes of determining the timing of any obligation
of the Company under this Section 2.1.1 to register the Registrable Securities, on the first business day immediately following the termination of the Blackout Period; and (C) the Company will use its commercially reasonable efforts to
file a Registration Statement covering the Registrable Securities as soon as reasonably practicable after the termination of the Blackout Period, but no later than sixty (60) days after the termination of the Blackout Period, and, upon filing,
use its commercially reasonable efforts to have such Registration Statement declared effective as soon as practicable thereafter. An Initial Demand Notice shall be effective only if it is received by the Company during the period beginning on the
Release Date and ending on the later of (x) the fifth anniversary of the Release Date and (y) one year after the date on which the Demanding Holders exercised Warrants that were included among the Registrable Securities. The Company shall
give written notice of its receipt of any Initial Demand Notice from any Investor(s) to all other registered holders of the Registrable Securities within ten (10) business days from the date of receipt of any such Initial Demand Notice. Once
made, a request for registration pursuant to an Initial Demand Notice provided in accordance with this Section may not be revoked, except that such a request for registration pursuant to an Initial Demand Notice may be revoked (and shall not be
deemed to have been made for purposes of determining the rights of the Investors under this Section), if (A) the Demanding Holders have received a notice of a Blackout Period from the Company and (B) the Demanding Holders provide written
notice to the Company within twenty (20) days of receipt of any such notice of a Blackout Period requesting such revocation for the purpose of preserving the right to request registration pursuant to an Initial Demand Notice at a time
subsequent thereto. For the avoidance of doubt, the Company may not delay the ability of the Demanding Holders to exercise their registration rights under this Agreement by way of giving notice of a Blackout Period more than once during any twelve
(12) month period, and any notice of a Blackout Period given by the Company to the Demanding Holders shall not be made within four months of any previous Blackout Period notice given by the Company. 
 2.1.2. Effective Registration. A registration will not count as a Demand Registration until the Registration Statement filed with
the Commission with respect to such Demand Registration has been declared effective and the Company has complied with all of its obligations under this Agreement with respect thereto. 
 2.1.3. Underwritten Offering. If a majority-in-interest of the Demanding Holders so elect and such holders so advise the Company as
part of their written demand for a Demand Registration, the offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an underwritten offering. In such event, the right of any holder to include its
Registrable Securities in such registration shall be conditioned upon such holder’s participation in such underwriting and the inclusion of such holder’s Registrable Securities in the underwriting to the extent provided herein. All
Demanding Holders shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such underwriting by a majority-in-interest of the holders initiating the Demand Registration. 
  

 4 

 2.1.4. Reduction of Offering. If the managing Underwriter or Underwriters for a
Demand Registration that is to be an underwritten offering advises the Company and the Demanding Holders in writing that the dollar amount or number of securities which the Demanding Holders desire to sell, taken together with all other shares of
Common Stock or other securities which the Company desires to sell and the securities, if any, as to which registration has been requested pursuant to written contractual piggy-back registration rights held by other shareholders of the Company who
desire to sell, exceeds the maximum dollar amount or maximum number of securities that can be sold in such offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such
offering (such maximum dollar amount or maximum number of securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such registration: (A) first, the Registrable Securities as to which Demand
Registration has been requested by the Demanding Holders (pro rata in accordance with the number of Registrable Securities which such Demanding Holder has requested be included in such registration, regardless of the number of Registrable Securities
held by each Demanding Holder) that can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the shares of Common Stock
or other securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses
(A) and (B), the securities for the account of other persons that the Company is obligated to register pursuant to written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities; and
(D) fourth, to the extent that the Maximum Number of Securities have not been reached under the foregoing clauses (A), (B), and (C), the securities that other security holders desire to sell that can be sold without exceeding the Maximum Number
of Securities. 
 2.1.5. Withdrawal. If a majority-in-interest of the Demanding Holders disapprove of the terms of any
underwriting or are not entitled to include all of their Registrable Securities in any offering, such majority-in-interest of the Demanding Holders may elect to withdraw from such offering by giving written notice to the Company and the Underwriter
or Underwriters of their request to withdraw prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Demand Registration. If the majority-in-interest of the Demanding Holders withdraws from a proposed
offering relating to a Demand Registration, then such registration shall not count as a Demand Registration provided for in this Section 2.1. 
 2.2. Piggy-Back Registration. 
 2.2.1. Piggy-Back Rights. If at any time on or after the Release Date
the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the
Company for its own account or for shareholders of the Company for their account (or by the Company and by shareholders of the Company including, without limitation, pursuant to Section 2.1), other than a Registration Statement (A) filed
in connection with any employee stock option or other benefit plan, (B) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (C) for an offering of debt that is convertible into equity
securities of the Company, or (D) for a dividend reinvestment plan, 

  

 5 

 
then the Company shall (x) give written notice of such proposed filing to the holders of Registrable Securities as soon as practicable but in no event
less than ten (10) business days before the anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing
Underwriter or Underwriters, if any, of the offering, and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of such number of shares of Registrable Securities as such holders may request in
writing within five (5) business days following receipt of such notice (a “Piggy-Back Registration”). For purposes of a Piggy-Back Registration (and not in the case of a Demand Registration), the exclusion from the definition of
Registrable Securities as to Registrable Securities which are then saleable under Rule 144 contained in the last sentence of the definition of “Registrable Securities” shall be inapplicable. The Company shall cause such Registrable
Securities to be included in such registration and shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed underwritten offering to permit the Registrable Securities requested to be included in a
Piggy-Back Registration to be included on the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution
thereof. All holders of Registrable Securities proposing to distribute their securities through a Piggy-Back Registration that involves an Underwriter or Underwriters shall enter into an underwriting agreement in customary form with the Underwriter
or Underwriters selected for such Piggy-Back Registration. 
 2.2.2. Reduction of Offering. If the managing Underwriter
or Underwriters for a Piggy-Back Registration that is to be an underwritten offering advises the Company and the holders of Registrable Securities in writing that the dollar amount or number of securities which the Company desires to sell, taken
together with securities, if any, as to which registration has been demanded pursuant to written contractual arrangements with persons other than the holders of Registrable Securities hereunder, the Registrable Securities as to which registration
has been requested under this Section 2.2, and the securities, if any, as to which registration has been requested pursuant to the written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum
Number of Securities, then the Company shall include in any such registration: 
 (i) If the registration is undertaken for
the Company’s account: (A) first, the securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been
reached under the foregoing clause (A), the securities, if any, including the Registrable Securities, as to which registration has been requested pursuant to written contractual piggy-back registration rights of security holders (pro rata in
accordance with the number of securities which each such person has actually requested to be included in such registration, regardless of the number of securities with respect to which such persons have the right to request such inclusion) that can
be sold without exceeding the Maximum Number of Securities; and 
 (ii) If the registration is a “demand”
registration undertaken at the demand of persons other than the holders of Registrable Securities pursuant to written contractual arrangements with such persons, (A) first, the securities for the account of the demanding persons that can be
sold without exceeding the Maximum Number of Securities; (B) second, to 

  

 6 

 
the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the shares of Common Stock or other securities that the
Company desires to sell that can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Registrable
Securities as to which registration has been requested under this Section 2.2 and any shares as to which registration has been requested pursuant to written contractual piggy-back registration rights which other security holders desire to sell
that can be sold without exceeding the Maximum Number of Securities (pro rata in accordance with the number of shares of Registrable Securities held by each such holder). 
 2.2.3. Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of
Registrable Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement. The Company may also elect to withdraw a registration statement at
any time prior to the effectiveness of the Registration Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders of Registrable Securities in connection with such Piggy-Back Registration as provided
in Section 3.3. 
 2.3. Registrations on Form S-3. The holders of at least thirty percent (30%) of Registrable Securities
may at any time and from time to time, request in writing that the Company register the resale of any or all of such Registrable Securities on Form S-3 or any similar short-form registration which may be available at such time (“Form
S-3”); provided, however, that the Company shall not be obligated to effect such request through an underwritten offering. Upon receipt of such written request, the Company will promptly give written notice of the proposed registration to all
other holders of Registrable Securities, and, as soon as practicable thereafter, effect the registration of all or such portion of such holder’s or holders’ Registrable Securities as are specified in such request, together with all or such
portion of the Registrable Securities of any other holder or holders joining in such request as are specified in a written request given within fifteen (15) business days after receipt of such written notice from the Company; provided, however,
that the Company shall not be obligated to effect any such registration pursuant to this Section 2.3 if Form S-3 is not available for such offering. Registrations effected pursuant to this Section 2.3 shall not be counted as Demand
Registrations effected pursuant to Section 2.1. 
 3. Certain Agreements Respecting Registrations. 
 3.1. Certain Registration Limitations and Procedures. 
 3.1.1. Limitations. Notwithstanding anything herein to the contrary, the Company shall not be obligated to effect any registration
pursuant to Section 2.1 of this Agreement if the holders of the Registrable Securities, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such
other securities (if any) at an aggregate price to the public of less than $500,000; provided, further, that the Company shall not be obligated to file a second Registration Statement until a Registration Statement that has been filed is counted as
a Demand Registration or is terminated or withdrawn. 
  

 7 

 3.1.2. Copies. The Company shall, prior to filing a Registration Statement or
prospectus, or any amendment or supplement thereto, furnish without charge to the holders of Registrable Securities included in such registration, and such holders’ legal counsel, copies of such Registration Statement as proposed to be filed,
each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including each preliminary
prospectus), and such other documents as the holders of Registrable Securities included in such registration or legal counsel for any such holders may request in order to facilitate the disposition of the Registrable Securities owned by such
holders. 
 3.1.3. Amendments and Supplements. Subject to the provisions of Section 3.2 hereof, the Company shall
use its commercially reasonable efforts to prepare and file with the Commission such amendments, including post-effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary
to keep such Registration Statement effective and in compliance with the provisions of the Securities Act until all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the
intended method(s) of distribution set forth in such Registration Statement (which period shall not exceed the sum of one hundred eighty (180) days plus any period during which any such disposition is interfered with by any stop order or
injunction of the Commission or any governmental agency or court and any period of suspension pursuant to Section 3.2) or such securities have been withdrawn from such registration. 
 3.1.4. Notification. After the filing of a Registration Statement, the Company shall promptly, and in no event more than two
(2) business days after such filing, notify the holders of Registrable Securities included in such Registration Statement of such filing, and shall further notify such holders promptly and confirm such advice in writing in all events within two
(2) business days of the occurrence of any of the following: (i) when such Registration Statement becomes effective; (ii) when any post-effective amendment to such Registration Statement becomes effective; (iii) the issuance or
threatened issuance by the Commission of any stop order (and the Company shall take all actions required to prevent the entry of such stop order or to remove it if entered); and (iv) any request by the Commission for any amendment or supplement
to such Registration Statement or any prospectus relating thereto or for additional information or of the occurrence of an event requiring the preparation of a supplement or amendment to such prospectus so that, as thereafter delivered to the
purchasers of the securities covered by such Registration Statement, such prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading, and promptly make available to the holders of Registrable Securities included in such Registration Statement any such supplement or amendment; except that before filing with the Commission a Registration Statement or prospectus or
any amendment or supplement thereto, including documents incorporated by reference, the Company shall furnish to the holders of Registrable Securities included in such Registration Statement and to the legal counsel for any such holders, copies of
all such documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity to review such documents and comment thereon, and the Company shall not file any Registration Statement
or prospectus or amendment or supplement thereto, including documents incorporated by reference, to which such holders or their legal counsel shall object. 
  

 8 

 3.1.5. State Securities Laws Compliance. The Company shall use its commercially
reasonable efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the holders of Registrable
Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other Governmental Authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the holders of Registrable
Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction
where it would not otherwise be required to qualify but for this paragraph 3.1.5 or subject itself to taxation in any such jurisdiction. 
 3.1.6. Agreements for Disposition. The Company shall enter into customary agreements (including, if applicable, an underwriting agreement in customary form) and take such other actions as are reasonably
required in order to expedite or facilitate the disposition of such Registrable Securities. The representations, warranties and covenants of the Company in any underwriting agreement which are made to or for the benefit of any Underwriters, to the
extent applicable, shall also be made to and for the benefit of the holders of Registrable Securities included in such registration statement. No holder of Registrable Securities included in such registration statement shall be required to make any
representations or warranties in the underwriting agreement except, if applicable, with respect to such holder’s organization, good standing, authority, title to Registrable Securities, lack of conflict of such sale with such holder’s
material agreements and organizational documents, and with respect to written information relating to such holder that such holder has furnished in writing expressly for inclusion in such Registration Statement. 
 3.1.7. Cooperation. The principal executive officer of the Company, the principal financial officer of the Company, the principal
accounting officer of the Company and all other officers and members of the management of the Company shall cooperate fully in any offering of Registrable Securities hereunder, which cooperation shall include, without limitation, the preparation of
the Registration Statement with respect to such offering and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys, accountants and potential holders. 
 3.1.8. Records. The Company shall make available for inspection by the holders of Registrable Securities included in such
Registration Statement, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other professional retained by any holder of Registrable Securities included in such Registration
Statement or any Underwriter, all financial and other records, pertinent corporate documents and properties of the Company, as shall be necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers,
directors and employees to supply all information requested by any of them in connection with such Registration Statement. 
 3.1.9. Delivery of Opinions and Other Documents. The Company shall furnish to each of the holders participating in any of the foregoing offerings, a signed counterpart, 

  

 9 

 
addressed to the participating holders, of (i) an opinion of counsel to the Company, dated the effective date of such Registration Statement (and, if
such registration includes an underwritten public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a “cold comfort” letter dated the effective date of such Registration
Statement (and, if such registration includes an underwritten public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent public accountants who have issued a report on the Company’s
financial statements included in such Registration Statement, in each case covering substantially the same matters with respect to such Registration Statement (and the prospectus included therein) and, in the case of such accountants’ letter,
with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’ letters delivered to underwriters in underwritten public offerings of securities.

 3.1.10. Earnings Statement. The Company shall comply with all applicable rules and regulations of the Commission and
the Securities Act, and make available to its shareholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, beginning within three (3) months after the effective date of the registration statement,
which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder. 
 3.1.11. Listing. The Company shall use its commercially reasonable efforts to cause all Registrable Securities included in any registration statement to be listed on such exchanges or otherwise designated for trading in the same
manner as similar securities issued by the Company are then listed or designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority of the Registrable Securities included in such
registration. 
 3.2. Obligation to Suspend Distribution. If after a registration statement relating to the registration of
Registrable Securities under Section 2 has been declared effective (“Effective Registration Statement”), upon the good faith determination by the Board of Directors of the Company that it is reasonably necessary to suspend the use of
such Effective Registration Statement or sales of Registrable Securities by holders under such Effective Registration Statement, the Company may, upon written notice (the “Suspension Notice”) to the holders, direct the holders to suspend
the use of or sales under such Effective Registration Statement. Upon the occurrence of any such suspension, the Company shall use its commercially reasonable efforts to take or cause to be taken such action as is necessary to permit resumed use of
such Effective Registration Statement promptly following the cessation of the Suspension Event giving rise to such suspension so as to permit the holders to resume use of and sales under such Effective Registration Statement as soon as practicable
thereafter. Upon cessation of the Suspension Event giving rise to such suspension, the Company shall promptly provide the holders with prompt written notice that the Suspension Event has ceased (the “End of Suspension Notice”). The holders
shall not effect any sales of the Registrable Securities pursuant to such Effective Registration Statement at any time after it has received a Suspension Notice from the Company and prior to receipt of an End of Suspension Notice. If so directed by
the Company in a Suspension Notice, each holder will deliver to the Company (at the expense of the Company) all copies, other than permanent file copies then in such holder’s possession, of any prospectuses covering the Registrable Securities
at the time of receipt of such Suspension Notice. 
  

 10 

 3.3. Registration Expenses. The Company shall bear all costs and expenses incurred by the Company
in connection with any Demand Registration pursuant to Section 2.1, any Piggy-Back Registration pursuant to Section 2.2, and any registration on Form S-3 effected pursuant to Section 2.3, and all expenses incurred in performing or
complying with its other obligations under this Agreement, whether or not the Registration Statement becomes effective, including, without limitation: (i) all registration and filing fees; (ii) fees and expenses of compliance with
securities or “blue sky” laws (including fees and disbursements of counsel in connection with blue sky qualifications of the Registrable Securities); (iii) printing expenses; (iv) the Company’s internal expenses (including,
without limitation, all salaries and expenses of its officers and employees); (v) the fees and expenses incurred in connection with the listing of the Registrable Securities as required by Section 3.1.11; (vi) National Association of
Securities Dealers, Inc. fees; (vii) fees and disbursements of counsel for the Company and fees and expenses for independent certified public accountants retained by the Company (including the expenses or costs associated with the delivery of
any opinions or comfort letters requested pursuant to Section 3.1.9); and (viii) the fees and expenses of any special experts retained by the Company in connection with such registration. The Company shall have no obligation to pay any
underwriting discounts or selling commissions attributable to the Registrable Securities being sold by the holders thereof, which underwriting discounts or selling commissions shall be borne by such holders. Additionally, in an underwritten
offering, all selling shareholders and the Company shall bear the expenses of the underwriter pro rata in proportion to the respective amount of shares each is selling in such offering. The holders of Registrable Securities shall bear all costs and
expenses incurred by them in connection with any such registration except to the extent specifically provided in this Section 3.3. 
 3.4. Information. The holders of Registrable Securities shall provide such information as may reasonably be requested by the Company, or the managing Underwriter, if any, in connection with the preparation of any Registration
Statement, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Section 2 and in connection with the Company’s obligation to comply with
federal and applicable state securities laws. 
 4. Indemnification and Contribution. 
 4.1. Indemnification by the Company. The Company agrees to indemnify and hold harmless each Investor and each other holder of Registrable
Securities, and each of their respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each person, if any, who controls an Investor and each other holder of Registrable Securities (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act) (each, a “Investor Indemnified Party”), from and against any expenses, losses, judgments, claims, damages or liabilities, whether joint or several, arising out
of or based upon any untrue statement (or allegedly untrue statement) of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus,
final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to such Registration Statement, or arising out of or based upon any omission (or alleged omission) to state a material fact required to be
stated therein or necessary to make the statements therein not misleading, or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder 

  

 11 

 
applicable to the Company and relating to action or inaction required of the Company in connection with any such registration; and the Company shall promptly
reimburse the Investor Indemnified Party for any legal and any other expenses reasonably incurred by such Investor Indemnified Party in connection with investigating and defending any such expense, loss, judgment, claim, damage, liability or action;
provided, however, that the Company will not be liable in any such case to the extent that any such expense, loss, claim, damage or liability arises out of or is based upon any untrue statement or allegedly untrue statement or omission or alleged
omission made in such Registration Statement, preliminary prospectus, final prospectus, or summary prospectus, or any such amendment or supplement, in reliance upon and in conformity with information furnished to the Company, in writing, by such
selling holder expressly for use therein. The Company also shall indemnify any Underwriter of the Registrable Securities, their officers, affiliates, directors, partners, members and agents and each person who controls such Underwriter on
substantially the same basis as that of the indemnification provided above in this Section 4.1. 
 4.2. Indemnification by Holders of
Registrable Securities. Each selling holder of Registrable Securities will, in the event that any registration is being effected under the Securities Act pursuant to this Agreement of any Registrable Securities held by such selling holder,
indemnify and hold harmless the Company, each of its directors and officers and each underwriter (if any), and each other person, if any, who controls such selling holder or such underwriter within the meaning of the Securities Act, against any
losses, claims, judgments, damages or liabilities, whether joint or several, insofar as such losses, claims, judgments, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or allegedly untrue
statement of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the
Registration Statement, or any amendment or supplement to the Registration Statement, or arise out of or are based upon any omission or the alleged omission to state a material fact required to be stated therein or necessary to make the statement
therein not misleading, if the statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by such selling holder expressly for use therein, and shall reimburse the Company, its directors
and officers, and each such controlling person for any legal or other expenses reasonably incurred by any of them in connection with investigation or defending any such loss, claim, damage, liability or action. Each selling holder’s
indemnification obligations hereunder shall be several and not joint and shall be limited to the amount of any net proceeds actually received by such selling holder. 
 4.3. Conduct of Indemnification Proceedings. Promptly after receipt by any person of any notice of any loss, claim, damage or liability or any action in respect of which indemnity may be sought pursuant to
Section 4.1 or 4.2, such person (the “Indemnified Party”) shall, if a claim in respect thereof is to be made against any other person for indemnification hereunder, notify such other person (the “Indemnifying Party”) in
writing of the loss, claim, judgment, damage, liability or action; provided, however, that the failure by the Indemnified Party to notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability which the Indemnifying Party
may have to such Indemnified Party hereunder, except and solely to the extent the Indemnifying Party is actually prejudiced by such failure. If the Indemnified Party is seeking indemnification with respect to any claim or action brought against the
Indemnified 

  

 12 

 
Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent that it wishes, jointly with all other
Indemnifying Parties, to assume control of the defense thereof with counsel satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume control of the defense of such claim or
action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided,
however, that in any action in which both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall have the right to employ separate counsel (but no more than one such separate counsel) to represent the
Indemnified Party and its controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Indemnified Party against the Indemnifying Party, with the fees and expenses of such counsel to
be paid by such Indemnifying Party if, based upon the written opinion of counsel of such Indemnified Party, representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. No
Indemnifying Party shall, without the prior written consent of the Indemnified Party, consent to entry of judgment or effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified Party is or could have
been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment or settlement includes an unconditional release of such Indemnified Party from all liability arising out of such claim or proceeding.

 4.4. Contribution. 
 4.4.1. If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any Indemnified Party in respect of any loss, claim, damage, liability or action referred to herein, then each
such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, claim, damage, liability or action in such proportion as is appropriate to
reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as well as any other relevant equitable considerations.
The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
 4.4.2. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.4 were determined
by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding Section 4.4.1. The amount paid or payable by an Indemnified Party as a result of
any loss, claim, damage, liability or action referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Party in connection with
investigating or defending any such action or claim. Notwithstanding the provisions of this Section 4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net proceeds (after
payment of any underwriting fees, discounts, commissions or taxes) actually 

  

 13 

 
received by such holder from the sale of Registrable Securities which gave rise to such contribution obligation. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 
 5. Underwriting and Distribution. 
 5.1. Rule
144. The Company covenants that it shall file all reports required to be filed by it under the Securities Act and the Exchange Act and shall take such further action as the holders of Registrable Securities may reasonably request, all to the
extent required from time to time to enable such holders to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 under the Securities Act, as such Rules may be amended
or interpreted from time to time, or any similar Rule or regulation hereafter adopted by the Commission. 
 6.
Miscellaneous. 
 6.1. Other Registration Rights. The Company represents and warrants that no person, other than a holder of
the Registrable Securities, persons who acquired the underwriters’ unit purchase options in the Initial Public Offering (and their Transferees) has any right to require the Company to register any shares of the Company’s capital stock for
sale or to include shares of the Company’s capital stock in any registration filed by the Company for the sale of shares of capital stock for its own account or for the account of any other person. The Company shall not enter into any agreement
granting any holder or prospective holder of any securities of the Company registration rights superior to the rights granted the Purchasers hereunder without the written consent of the holders of a majority of the Registrable Securities.

 6.2. Assignment; No Third Party Beneficiaries. This Agreement and the rights, duties and obligations of the Company hereunder may
not be assigned or delegated by the Company in whole or in part. This Agreement and the rights, duties and obligations of the holders of Registrable Securities hereunder may be freely assigned or delegated by such holder of Registrable Securities in
conjunction with and to the extent of any transfer of Registrable Securities by any such holder. This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each Investor and Transferee. This Agreement is not
intended to confer any rights or benefits on any persons that are not party hereto other than as expressly set forth in Section 4 and this Section 6.2. 
 6.3. Notices. All notices, demands, requests, consents, approvals or other communications required or permitted to be given hereunder or which are given with respect to this Agreement, other than as expressly
set forth in Section 2.1 shall be in writing and shall be personally served, delivered by reputable air courier service with charges prepaid, or transmitted by hand delivery or facsimile, addressed as set forth below, or to such other address
as such party shall have specified most recently by written notice. Notice shall be deemed given on the date of service or transmission if personally served or transmitted by facsimile; provided, that if such service or transmission is not on a
business day or is after normal business hours, then such notice shall be deemed given on the next business day. Notice otherwise sent as provided herein shall be deemed given on the next business day following timely delivery of such notice to a
reputable air courier service with a pre-paid order for next-day delivery. 
  

 14 

 If to the Company, to: 
 Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, Illinois 60606 
 Attn: Bobba Venkatadri, CEO 
 Fax: (312) 922-9283 
 with a copy to: 
 Hayden Bergman Rooney 
 Professional Corporation 
 150 Post Street, Suite 650 
 San Francisco, California 94108 
 Attn: Kevin K. Rooney, Esq. 
 Fax: (415) 399-9320 
 To an Investor, to: 
 Marillion Pharmaceuticals India Pvt. Ltd. 
 #20B; ASCI College Park 
 Road No. 3 
 Banjara Hills, Hyderabad 
 500 034 
 Fax: 0091-40-2355087 
 Business Ventures Corp. 
 603 W 13th #1A-247 
 Austin Texas 78701 
 Fax: (512) 263-7596 
  Trans-India Investors Limited 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
  Bobba Venkatadri 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
 Craig Colmar 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
 Nalluru Murthy 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
  

 15 

 Narayanan Vaghul 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
 Edmund Olivier 
 c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
  Rasheed Yar Kahn 
  c/o Trans-India Acquisition Corporation 
 300 South Wacker Drive, Suite 1000 
 Chicago, IL 60606 
 Fax: (312) 922-9283 
 with a copy to: 
 Hayden Bergman Rooney 
 Professional Corporation 
 150 Post Street, Suite 650 
 San Francisco, California 94108 
 Attn: Kevin K. Rooney, Esq. 
 Fax: (415) 399-9320 
 6.4. Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not
affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this
Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 
 6.5.
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument. 
  

 16 

 6.6. Entire Agreement. This Agreement (including all agreements entered into pursuant hereto and
all certificates and instruments delivered pursuant hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements, representations, understandings,
negotiations and discussions between the parties, whether oral or written. 
 6.7. Modifications and Amendments. No amendment,
modification or termination of this Agreement shall be binding upon any party unless executed in writing by such party. 
 6.8. Titles and
Headings. Titles and headings of sections of this Agreement are for convenience only and shall not affect the construction of any provision of this Agreement. 
 6.9. Waivers and Extensions. Any party to this Agreement may waive any right, breach or default which such party has the right to waive, provided that such waiver will not be effective against the waiving party
unless it is in writing, is signed by such party, and specifically refers to this Agreement. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred. Any waiver may be conditional. No waiver
of any breach of any agreement or provision herein contained shall be deemed a waiver of any preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance of any
obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts. 
 6.10. Remedies
Cumulative. In the event that the Company fails to observe or perform any covenant or agreement to be observed or performed under this Agreement, the Investor or any other holder of Registrable Securities may proceed to protect and enforce its
rights by suit in equity or action at law, whether for specific performance of any term contained in this Agreement or for an injunction against the breach of any such term or in aid of the exercise of any power granted in this Agreement or to
enforce any other legal or equitable right, or to take any one or more of such actions, without being required to post a bond. None of the rights, powers or remedies conferred under this Agreement shall be mutually exclusive, and each such right,
power or remedy shall be cumulative and in addition to any other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise. 
 6.11. Governing Law. This Agreement shall be governed by, interpreted under, and construed in accordance with the laws of the State of Delaware
applicable to agreements made and to be performed within the State of Delaware, without giving effect to any choice-of-law provisions thereof that would compel the application of the substantive laws of any other jurisdiction. 
 6.12. Waiver of Trial by Jury. Each party hereby irrevocably and unconditionally waives the right to a trial by jury in any action, suit,
counterclaim or other proceeding (whether based on contract, tort or otherwise) arising out of, connected with or relating to this Agreement, the transactions contemplated hereby, or the actions of the Investor in the negotiation, administration,
performance or enforcement hereof. 
 [Remainder of Page Intentionally Left Blank] 
  

 17 

 IN WITNESS WHEREOF, the parties have duly executed this Registration Rights Agreement as of the date
first written above. 
  
  
			
	TRANS-INDIA ACQUISITION CORPORATION
		
	 By:
	 	  
		 	 Name: Bobba Venkatadri

		 	 Title:   Chief Executive Officer

	
	INVESTORS:
	
	MARILLION PHARMACEUTICALS INDIA PVT. LTD.
		
	 By:
	 	  
		 	 Name: Ramesh Alur

		 	 Title:   Authorized Officer

	
	BUSINESS VENTURES CORP.
		
	 By:
	 	  
		 	 Name: Steven P. Colmar

		 	 Title:   President

	
	TRANS-INDIA INVESTORS LIMITED
		
	 By:
	 	  
		 	 Name:

		 	 Title:

	
	  
	Bobba Venkatadri
	
	  
	Craig Colmar
	
	  
	Nalluru Murthy
	
	  
	Narayanan Vaghul

  [Signature Page to Registration Rights Agreement] 

			
	  
	Edmund Olivier
	
	  
	 Rasheed Yar Khan

 [Signature Page to Registration Rights Agreement]Subscription Agreement

 EXHIBIT 10.14 
 REGULATION S SUBSCRIPTION AGREEMENT 
 This Regulation S Subscription Agreement (this
“Agreement”) is made as of November 13, 2006 by and among Trans-India Acquisition Corporation, a Delaware corporation (the “Company”), Marillion Pharmaceuticals India Pvt. Ltd., an Indian company, and Trans-India Investors,
Limited, a Belize company (each a “Purchaser,” and collectively, the “Purchasers”). 
 WHEREAS, the Company has filed
with the Securities and Exchange Commission (“SEC”) a registration statement on Form S-1, as amended (the “Registration Statement”), in connection with the Company’s initial public offering (the “IPO”) of up to
11,500,000 units, each unit (“Unit”) consisting of one share of the Company’s common stock, $0.0001 par value (the “Common Stock”) and one warrant (the “Warrants”), each Warrant to purchase one share of Common
Stock. 
 WHEREAS, Marillion Pharmaceuticals India Pvt. Ltd. is an existing stockholder of the Company. 
 WHEREAS, Trans-India Investors, Limited, has obtained loans from certain directors and officers of the Company for purposes of purchasing a portion of
the Placement Units (as defined below). 
 WHEREAS, the Company desires to sell in a private placement to the Purchasers (the
“Placement”) an aggregate of 75,000 units (the “Placement Units”) substantially identical to the Units to be issued in the IPO pursuant to the terms and conditions hereof and to be set forth in the Registration Statement, except
that the Placement Units, Common Stock and Warrants to be issued in the Placement shall not be registered under the Securities Act of 1933, as amended (the “Securities Act”), and issued in accordance with Regulation S promulgated by the
Securities and Exchange Commission under the Act. 
 WHEREAS, the Purchasers desire to acquire the Placement Units. 
 WHEREAS, the Placement Units, Common Stock and Warrants to be issued in the Placement shall be placed in escrow pursuant to the terms of the Securities
Escrow Agreement to be filed as an exhibit to the Registration Statement. 
 WHEREAS, the Warrants included in the Placement Units shall be
governed by the Warrant Agreement to be filed as an exhibit to the Registration Statement. 
 NOW THEREFORE, in consideration of the mutual
agreements herein contained, the parties hereto agree as follows: 
 1. Purchase of Units. Subject to the terms and conditions hereof, the Company
shall issue and sell to the Purchasers and the Purchasers shall severally buy from the Company 75,000 Placement Units at a purchase price of $8.00 per Placement Unit, or $600,000 in the aggregate (the “Purchase Price”), in the amount of
Placement Units specified opposite the name of each Purchaser in the column designated “Number of Placement Units” on Exhibit A hereto. 
  

 1 

 2. Closing. The closing of the purchase and sale of the Placement Units (the “Closing”) will take place
immediately prior to and conditional upon the consummation of the IPO. At the Closing, the Company shall deliver to the escrow agent as described in the Registration Statement, on behalf of the Purchasers in accordance with the Securities Escrow
Agreement, a certificate or certificates representing the Placement Units, registered in the Purchaser’s name, representing the number of Placement Units to be purchased by the Purchaser at the Closing, against payment of the purchase price
therefore in the amount set forth in the column designated “Purchase Price” opposite such Purchaser’s name on Exhibit A hereto by certified check or wire transfer of funds per the Company’s instructions. Simultaneous with the
closing of the IPO, the Company shall deposit or direct the deposit of the Purchase Price into the trust account described in the Registration Statement. 
 3. Separate Agreements. The Company’s agreement with each of the Purchasers hereunder is a separate agreement, the obligations of each of the Purchasers hereunder are several and not joint, and the sale of the Placement Units to
each of the Purchasers is a separate transaction. 
 4. Representations and Warranties of the Purchasers. Each Purchaser hereby represents and
warrants to the Company that: 
 (a) No Government Recommendation or Approval. Purchaser understands that no United States federal or
state agency or similar agency of any other country, has passed upon or made any recommendation or endorsement of the Company or the IPO of the Units. 
 (b) Not a “U.S. Person”. Purchaser is not a “U.S. Person” as defined in Rule 902 of Regulation S promulgated under the Securities Act, was not organized under the laws of any United States
jurisdiction. At the time the purchase order for this transaction was originated, Purchaser was outside the United States. 
 (c)
Intent. Purchaser is purchasing the Placement Units solely for investment purposes, for the Purchaser’s own account and not for the account or benefit of any U.S. Person, and not with a view towards the distribution or dissemination
thereof and Purchaser has no present arrangement to sell the Placement Units to or through any person or entity. Purchaser understands that the Placement Units must be held indefinitely unless such Placement Units are resold in accordance with the
provisions of Regulation S, are subsequently registered under the Securities Act or an exemption from registration is available. 
 (d)
Restrictions on Transfer. Purchaser understands that the Placement Units are being offered in a transaction not involving a public offering in the United States within the meaning of the Securities Act. The Placement Units have not been
registered under the Securities Act, and, if in the future Purchaser decides to offer, resell, pledge or otherwise transfer the Placement Units, such Placement Units may be offered, resold, pledged or otherwise transferred only (A) pursuant to
an effective registration statement filed under the Securities Act, (B) to a non-U.S. Person in an offshore transaction in accordance with Rule 903 or Rule 904 of Regulation S of the Securities Act, (C) pursuant to the resale limitations
set forth in Rule 905 of Regulation S, (D) pursuant to an exemption from registration under the Securities Act provided by Rule 144 thereunder (if available), or (E) pursuant to any other exemption from the registration requirements of the
Securities Act, and in each case in accordance with any 

  

 2 

 
applicable securities laws of any state of the United States or any other jurisdiction. Purchaser acknowledges, agrees and covenants that it will not engage
in hedging transactions with regard to the Placement Units prior to the expiration of the distribution compliance period specified in Rule 903 of Regulation S promulgated under the Securities Act, unless in compliance with the Securities Act.
Purchaser agrees that if any transfer of its Placement Units or any interest therein is proposed to be made, as a condition precedent to any such transfer, Purchaser may be required to deliver to the Company an opinion of counsel satisfactory to the
Company. Absent registration or another exemption from registration, Purchaser agrees that it will not resell the securities constituting the Placement Units to U.S. Persons or within the United States. 
 (e) Sophisticated Investor. 
 (i)
Purchaser is sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Placement Units. 
 (ii) Purchaser is able to bear the economic risk of his investment in the Placement Units for an indefinite period of time because none of the Placement Units have been registered under the Securities Act and therefore cannot be sold unless
subsequently registered under the Securities Act or an exemption from such registration is available. 
 (f) Independent
Investigation. Purchaser, in making the decision to purchase the Placement Units, has relied upon an independent investigation of the Company and has not relied upon any information or representations made by any third parties or upon any oral
or written representations or assurances from the Company, its officers, directors or employees or any other representatives or agents of the Company, other than as set forth in this Agreement. Purchaser is familiar with the business, operations and
financial condition of the Company and has had an opportunity to ask questions of, and receive answers from, the Company’s officers and directors concerning the Company and the terms and conditions of the offering of the Placement Units and has
had full access to such other information concerning the Company as Purchaser has requested. 
 (g) Authority. This Agreement has been
validly authorized, executed and delivered by Purchaser and is a valid and binding agreement enforceable in accordance with its terms, subject to the general principles of equity and to bankruptcy or other laws affecting the enforcement of
creditors’ rights generally. The execution, delivery and performance of this Agreement by Purchaser does not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which Purchaser is a party.

 (h) No Legal Advice from Company or its Legal Counsel. Purchaser acknowledges that it has had the opportunity to review this
Agreement and the transactions contemplated by this Agreement and the other agreements entered into between the parties hereto with Purchaser’s own legal counsel and investment and tax advisors. Except for any statements or representations of
the Company made in this Agreement and the other agreements entered into between the parties hereto, Purchaser is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of its representatives
or agents or legal counsel for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction. 
  

 3 

 (i) Reliance on Representations and Warranties. Purchaser understands that the Placement Units are
being offered and sold to Purchaser in reliance on specific provisions of United States federal securities laws and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and
understandings of Purchaser set forth in this Agreement in order to determine the applicability of such provisions. 
 (j) No
Advertisements. Purchaser is not subscribing for the Placement Units as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or
radio, or presented at any seminar or meeting. 
 (k) Legend. Purchaser acknowledges and agrees that the Placement Units, shares of
Common Stock and the Warrants comprising the Placement Units, and when issued the shares of Common Stock underlying the Warrants, shall bear a restricted legend (the “Legend”), in the form and substance as set forth in Section 5
hereof, prohibiting the offer, sale, pledge or transfer of the securities, except (i) pursuant to an effective registration statement filed under the Securities Act, (ii) in accordance with the applicable provisions of Regulation S,
promulgated under the Securities Act, (iii) pursuant to an exemption from registration provided by Rule 144 under the Securities Act (if available), and (iv) pursuant to any other exemption from the registration requirements of the
Securities Act. 
 5. Legends; Restrictions on Transfer. 
 (a) Legend. The Company will issue the Placement Units, shares of Common Stock and the Warrants comprising the Placement Units, and when issued the shares of Common Stock underlying the Warrants, purchased by
Purchaser in the name of Purchaser. Such Company securities will bear the following Legend and appropriate “stop transfer” instructions: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT, (B) TO A NON U.S. PERSON IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C) PURSUANT TO THE RESALE
LIMITATIONS SET FORTH IN RULE 905 OF REGULATIONS S UNDER THE SECURITIES ACT, (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE), OR (E) PURSUANT TO ANY OTHER EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS
IN COMPLIANCE WITH THE SECURITIES ACT. 
 (b) Purchaser’s Compliance. Nothing in this Section 5 shall affect in any way the

  

 4 

 
Purchaser’s obligations and agreement to comply with all applicable securities laws upon resale of the Placement Units, and the Shares and Warrants
underlying the Placement Units. 
 (c) Company’s Refusal to Register Transfer of Units. The Company shall refuse to register any
transfer of the Placement Units, shares of Common Stock and the Warrants comprising the Placement Units, and when issued the shares of Common Stock underlying the Warrants, not made in accordance with (i) the provisions of Regulation S,
(ii) pursuant to an effective registration statement filed under the Securities Act, or (iii) pursuant to an available exemption from the registration requirements of the Securities Act. 
 6. Waiver and Indemnification. Each Purchaser and its officers and directors hereby waive any and all rights to assert any present or future claims, including any
right of rescission, against the Company, I-Bankers Securities, Inc. (“I-Bankers”), the other underwriters in the IPO or the officers, directors, attorneys, agents or employees of any of them with respect to its purchase of the Placement
Units, and each Purchaser agrees to indemnify and hold the Company, I-Bankers, the other underwriters in the IPO and the officers, directors, attorneys, agents or employees of any of them harmless from all losses, damages or expenses that relate to
claims or proceedings brought against the Company, I-Bankers or such other underwriters and the officers, directors, attorneys, agents or employees of any of them by any transferees, heirs, assigns or any subsequent holders of the Placement Units.

 7. Counterparts. This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be
an original, and all such counterparts shall together constitute but one and the same instrument. 
 8. Entire Agreement. This Agreement contains the
entire agreement of the parties hereto with respect to the subject matter hereof and, except as expressly provided herein, may not be changed or modified except by an instrument in writing signed by the party to the charged. 
 9. Binding Effect. This Agreement shall be binding upon and inure to the benefit of the respective parties hereto and their legal representatives, successors and
assigns. 
 10. Governing Law. This Agreement shall for all purposes be deemed to be made under and shall be construed in accordance with the laws of
the State of New York. Each of the parties hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. Each of the parties hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum. 
 [Remainder of Page Intentionally Left Blank] 
  

 5 

 IN WITNESS WHEREOF, the parties have duly executed this Regulation S Subscription Agreement as of the
date first written above. 
  

			
	TRANS-INDIA ACQUISITION CORPORATION
		
	By:	 	 /S/ BOBBA VENKATADRI

		 	Name: Bobba Venkatadri
		 	Title: Chief Executive Officer
	
	MARILLION PHARMACEUTICALS INDIA PVT. LTD.
		
	By:	 	 /S/ RAMESH ALUR

		 	Name: Ramesh Alur
		 	Title: Authorized Officer
	
	TRANS-INDIA INVESTORS, LIMITED
		
	By:	 	 /S/ JOANNE ZORE

		 	Name: Joanne Zore
		 	Title: Director

 EXHIBIT A 
  

						
	 Purchaser Name
	  	Number of Placement Units	  	Purchase Price
	 Marillion Pharmaceuticals India Pvt. Ltd.
	  	23,749	  	$	189,992
	 Trans-India Investors, Limited
	  	51,251	  	$	410,008
		  	 	  	 	 
	 Total
	  	75,000	  	$	600,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]